Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 08/08/2016 10:01:33 AM
Post# of 30066
Avatar
Posted By: bms
Re: greyhawk #23778
All 15 patients who received ESS survived;
Mortality in this ESS study was 6.25%, as compared to a 30.3% mortality rate for a comparable population from the National Burn Repository (P < .05), indicating that ESS may potentially reduce mortality by over 75% in this pediatric patient population;
These results indicate that autologous ESSs reduce mortality and requirements for donor skin harvesting, for grafting of full-thickness burns of greater than 50% TBSA.













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site